(ARGX) argenx - Performance 47% in 12m
Compare ARGX with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
92.18%
#4 in Group
Rel. Strength
89.82%
#779 in Universe
Total Return 12m
46.97%
#25 in Group
Total Return 5y
326.00%
#7 in Group
P/E 46.5
86th Percentile in Group
P/E Forward 88.5
91th Percentile in Group
PEG -
(unknown) Percentile in Group
FCF Yield -0.25%
77th Percentile in Group
12m Total Return: ARGX (47%) vs XBI (-11%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
ABBV NYSE AbbVie |
-2.97% | 17.7% | 234% | 84.1 | 16.4 | 0.42 | -49.6% | -19% |
UTHR NASDAQ United Therapeutics |
0.72% | 36.6% | 226% | 13 | 11.3 | 1.43 | 83.8% | 78.5% |
HLN NYSE Haleon |
-3.97% | 23.4% | 39.7% | 25.6 | 20.9 | 1.85 | -38.6% | -24.4% |
AMGN NASDAQ Amgen |
-1.63% | 14.1% | 68.5% | 40.5 | 14.8 | 1.04 | -18.8% | -20% |
LONN SW Lonza |
-7.89% | 0.58% | 37% | 60.5 | 31.8 | 1.16 | 12.6% | -10.3% |
NBIX NASDAQ Neurocrine Biosciences |
-5.39% | -21.4% | 18.7% | 33.6 | 22.8 | 0.27 | 61.5% | 31.6% |
BIM PA Biomerieux |
1.3% | 15.8% | 12.1% | 31.4 | 25.8 | 1.47 | -47.6% | -26.9% |
KMDA NASDAQ Kamada |
1.65% | 24.1% | 14.1% | 27 | 25 | 1 | 58.7% | 15% |
Performance Comparison: ARGX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ARGX
Total Return (including Dividends) | ARGX | XBI | S&P 500 |
---|---|---|---|
1 Month | -6.26% | -5.85% | -3.01% |
3 Months | -5.89% | -11.95% | -3.15% |
12 Months | 46.97% | -11.00% | 10.19% |
5 Years | 326.00% | 0.65% | 129.24% |
Trend Score (consistency of price movement) | ARGX | XBI | S&P 500 |
1 Month | -27.0% | -59.8% | -5.5% |
3 Months | -76.0% | -70.5% | -58.4% |
12 Months | 92.4% | -6.9% | 84.1% |
5 Years | 92.3% | -50% | 84.4% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #79 | -0.44% | -3.36% |
3 Month | #46 | 6.88% | -2.83% |
12 Month | #26 | 65.1% | 33.4% |
5 Years | #8 | 323% | 85.8% |
FAQs
Does ARGX argenx outperforms the market?
Yes,
over the last 12 months ARGX made 46.97%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.00%.
Over the last 3 months ARGX made -5.89%, while XBI made -11.95%.
Over the last 3 months ARGX made -5.89%, while XBI made -11.95%.
Performance Comparison ARGX vs Indeces and Sectors
ARGX vs. Indices ARGX is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 0.71% | -3.25% | 6.24% | 36.8% |
US NASDAQ 100 | QQQ | 1.69% | -2.20% | 7.01% | 38.4% |
US Dow Jones Industrial 30 | DIA | 0.51% | -4.12% | 5.32% | 37.5% |
German DAX 40 | DAX | 2.01% | -2.88% | -10.6% | 25.3% |
Shanghai Shenzhen CSI 300 | CSI 300 | 1.0% | -6.49% | 21.5% | 37.9% |
Hongkong Hang Seng | HSI | -1.26% | -9.03% | 15.5% | 29.6% |
India NIFTY 50 | INDA | -0.32% | -14.1% | 16.6% | 46.3% |
Brasil Bovespa | EWZ | 0.60% | -14.6% | 14.2% | 58.7% |
ARGX vs. Sectors ARGX is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 2.25% | -2.45% | -1.87% | 27.8% |
Consumer Discretionary | XLY | -0.05% | -2.43% | 2.88% | 32.9% |
Consumer Staples | XLP | -2.08% | -4.42% | 5.40% | 35.9% |
Energy | XLE | -0.38% | -14.3% | 0.66% | 46.2% |
Financial | XLF | 0.23% | -3.56% | -5.92% | 24.7% |
Health Care | XLV | 0.29% | -3.10% | 10.9% | 45.3% |
Industrial | XLI | 0.40% | -5.57% | 6.95% | 38.4% |
Materials | XLB | -0.39% | -6.77% | 14.4% | 50.9% |
Real Estate | XLRE | -1.33% | -3.57% | 9.36% | 33.6% |
Technology | XLK | 1.84% | -2.25% | 11.4% | 45.0% |
Utilities | XLU | -2.58% | -7.08% | 7.12% | 21.7% |
Aerospace & Defense | XAR | 1.31% | -7.54% | 2.32% | 26.0% |
Biotech | XBI | 5.27% | -0.41% | 23.9% | 58.0% |
Homebuilder | XHB | 0.21% | -6.41% | 25.6% | 54.7% |
Retail | XRT | -1.59% | -5.76% | 10.3% | 51.8% |